Addition of Reference
In the original publication [1], “Nanotechnology-Aided Advancement in Combating the Cancer Metastasis”, Reference [136] (see [2]) “Avula, L.R.; Grodzinski, P. Nanotechnology-aided advancement in the combating of cancer metastasis. Cancer Metastasis Rev. 2022, 41, 383–404. https://doi.org/10.1007/s10555-022-10025-7” was not cited. The citation has now been inserted into Section 9 “Every year, almost 500 million doses of these two vaccines were administered in the United States alone. mRNA-based cancer therapies will become accessible shortly due to their efficacy as a delivery mechanism [134–136]”. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
References
- Singh, A.K.; Malviya, R.; Prajapati, B.; Singh, S.; Yadav, D.; Kumar, A. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899. [Google Scholar] [CrossRef] [PubMed]
- Avula, L.R.; Grodzinski, P. Nanotechnology-aided advancement in the combating of cancer metastasis. Cancer Metastasis Rev. 2022, 41, 383–404. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).